Libivirumab

Tax included
Libivirumab (17.1.41) is a humanized anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively.
HY-P99703

Data sheet

Size
Multiple sizes
Reactivity
HBV
CAS
569658-79-3